RecruitingNCT02838927

Survey on Epidemiology of Hypoparathyroidism in France

Epi-Hypo: Survey on Epidemiology of Hypoparathyroidism in France

Sponsor

European Georges Pompidou Hospital

Enrollment

3,000 participants

Start Date

Jul 1, 2016

Study Type

OBSERVATIONAL

Conditions

Hypoparathyroidism

Summary

Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is creating a national registry in France to track patients with chronic hypoparathyroidism — a long-term condition where the body does not produce enough parathyroid hormone, leading to low calcium levels in the blood — to better understand how common it is and how patients are affected over time. **You may be eligible if...** - You have been diagnosed with chronic hypoparathyroidism - You live in France **You may NOT be eligible if...** - You do not want your health data included in the registry - You have pseudo-hypoparathyroidism, where the body resists parathyroid hormone rather than not producing it - You have acute (short-term and temporary) hypoparathyroidism Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

No intervention

Locations(57)

Felix Guyon Hospital

Saint-Denis, La Réunion, France

Hôpital Privé de Provence

Aix-en-Provence, France

Amiens University Hospital

Amiens, France

Clinic Auch Area

Auch, France

Henri Mondor Hospital

Aurillac, France

Jean Minjoz Hospital

Besançon, France

Blanquefort

Blanquefort, France

Avicenne Hospital, AP-HP

Bobigny, France

Jean Verdier Hospital, AP-HP

Bondy, France

University Hospital

Bordeaux, France

Bourgoin Jallieu Hospital

Bourgoin, France

La Cavale Blanche Hospital

Brest, France

Côte de Nacre Hospital

Caen, France

Henri Mondor Hospital, APHP

Créteil, France

Dax-Côte d'Argent Hospital

Dax, France

University Hospital

Dijon, France

Grenoble Alpes Hospital

Grenoble, France

CHD Vendée

La Roche-sur-Yon, France

Kremlin-Bicêtre Hospital, APHP

Le Kremlin-Bicêtre, France

Le Mans Hospital

Le Mans, France

Libourne Hospital

Libourne, France

Claude Huriez Hospital

Lille, France

Edouard Herriot Hospital, HCL

Lyon, France

La Conception Hospital, AP-HM

Marseille, France

Clinic Metz Area

Metz, France

Mercy Hospital

Metz, France

Clinic area

Mérignac, France

Arnaud de Villeneuve Hospital

Montpellier, France

Brabois Hospital

Nancy, France

University Hospital

Nantes, France

University Hospital

Nice, France

Georges Renon Hospital

Niort, France

Caremeau Hospital

Nîmes, France

European Georges Pompidou Hospital, APHP

Paris, France

Clinic Paris Area

Paris, France

Cochin Hospital, APHP

Paris, France

Lariboisière Hospital, APHP

Paris, France

Necker Hospital, AP-HP

Paris, France

Pitié-Salpêtrière Hospital, APHP

Paris, France

Saint-Louis Hospital, AP-HP

Paris, France

Tenon Hospital, APHP

Paris, France

Passy Hospital

Passy, France

Clinic Poitiers Area

Poitiers, France

Laennec Hospital

Quimper, France

Reims University Hospital

Reims, France

Clinic Rennes Area

Rennes, France

Charles Nicolle Hospital

Rouen, France

Saint Florent Le Vieil

Saint-Florent-le-Vieil, France

Clinic Area

Saint-Junien, France

Clinique du Landy

Saint-Ouen, France

Hautepierre Hospital

Strasbourg, France

Sainte Anne Hospital, HIA

Toulon, France

Larrey Hospital

Toulouse, France

Guy Chatiliez Hospital

Tourcoing, France

Bretonneau Hospital

Tours, France

Valenciennes Hospital

Valenciennes, France

CHIV - Lucie et Raymond Aubrac

Villeneuve-Saint-Georges, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02838927

Related Trials

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

NCT070819972 locations

A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)

NCT072646341 location

An Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

NCT075402861 location

Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

NCT075307051 location

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

NCT071974501 location